| 10-Q | 2019-09-30 | Filed 2019-11-04 |
| 10-Q | 2019-06-30 | Filed 2019-08-09 |
| 10-Q | 2019-03-31 | Filed 2019-05-15 |
| 10-K | 2018-12-31 | Filed 2019-04-16 |
| 10-Q | 2018-09-30 | Filed 2018-11-14 |
| 10-Q | 2018-06-30 | Filed 2018-08-13 |
| 10-Q | 2018-03-31 | Filed 2018-05-15 |
| 10-K | 2017-12-31 | Filed 2018-04-16 |
| 10-Q | 2017-09-30 | Filed 2017-10-12 |
| 10-Q | 2017-06-30 | Filed 2017-08-03 |
| 8-K | 2020-05-12 | |
| 8-K | 2020-03-30 |
| Comps ($'000 TTM) | Market Cap | Gross Margin | EV/EBITDA | Ret on Assets | Assets | Liabilities | Revenue | G Profit | Net Income | EBITDA | EV |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gulfslope Energy (GSPE) | 43,691 | -3.7 | -45% | 30,784 | 31,113 | 0 | 0 | -13,724 | -11,439 | 42,552 | |
| Solis Tek (SLTK) | 43,678 | 51% | -25.8 | -163% | 1,378 | 6,785 | 1,895 | 973 | -2,244 | -1,693 | 43,612 |
| Where Food Comes From (WFCF) | 43,107 | 42% | 21.1 | 4% | 19,538 | 6,989 | 15,075 | 6,341 | 759 | 1,882 | 39,712 |
| CCUR (CCUR) | 42,638 | 0% | 7.9 | 6% | 65,998 | 9,965 | 5,021 | 0 | 4,245 | 4,508 | 35,471 |
| Smartag International (SMRN) | 42,619 | 100% | -140.1 | -347% | 87 | 31 | 1 | 1 | -304 | -304 | 42,532 |
| Mastermind (MMND) | 42,338 | 88% | 91.3 | 16% | 2,419 | 256 | 3,727 | 3,297 | 375 | 459 | 41,906 |
| Newgioco (NWGI) | 42,058 | 0% | -17.6 | -21% | 25,358 | 17,927 | 25,127 | 0 | -5,400 | -2,117 | 37,352 |
| Parallax Health Sciences (PRLX) | 41,922 | 280% | -5.4 | -333% | 2,373 | 7,209 | 82 | 229 | -7,914 | -7,871 | 42,507 |
| Sanuwave Health (SNWV) | 41,781 | 42% | -5.8 | -467% | 1,644 | 14,962 | 693 | 290 | -7,680 | -7,149 | 41,378 |
| ATI Nationwide Holding (ATIN) | 41,622 | -862.6 | -3,752% | 1 | 19 | 0 | 0 | -48 | -48 | 41,621 | |
| India Globalization Capital (IGC) | 40,759 | 2% | -5.1 | -16% | 32,887 | 1,645 | 6,297 | 141 | -5,284 | -5,207 | 26,696 |
| Portsmouth Square (PRSI) | 40,747 | 24% | 13.7 | 4% | 62,481 | 135,874 | 59,500 | 14,496 | 2,290 | 12,407 | 169,553 |
| Medovex (MDVX) | 40,687 | 75% | -3.7 | -66% | 17,580 | 8,020 | 6,498 | 4,897 | -11,616 | -10,904 | 40,342 |
| MJ Holdings (MJNE) | 40,433 | 31% | -12.8 | -27% | 11,993 | 5,152 | 779 | 240 | -3,278 | -3,125 | 39,929 |
| Barfresh (BRFH) | 40,406 | 56% | -16.8 | -60% | 6,592 | 4,566 | 3,782 | 2,137 | -3,950 | -2,523 | 42,352 |
| EPHS Holdings (STNN) | 40,182 | -65.5 | -21% | 3,196 | 2,664 | 0 | 0 | -658 | -638 | 41,794 | |
| Pharmacyte Biotech (PMCB) | 39,956 | -9.9 | -75% | 5,338 | 804 | 0 | 0 | -4,016 | -4,016 | 39,911 | |
| Guardion Health Sciences (GHSI) | 39,881 | 61% | -5.4 | -76% | 8,955 | 906 | 665 | 403 | -6,819 | -6,353 | 34,326 |
| Super League Gaming (SLGG) | 39,507 | 54% | -1.1 | -138% | 18,773 | 1,567 | 822 | 443 | -25,991 | -25,147 | 26,921 |
| Smith Midland (SMID) | 39,433 | 20% | 13.6 | 3% | 40,403 | 20,126 | 34,250 | 6,971 | 1,178 | 2,992 | 40,678 |
| Balance Sheet ($'000) | 2017-06-30 | 2017-09-30 | 2017-12-31 | 2018-03-31 | 2018-06-30 | 2018-09-30 | 2018-12-31 | 2019-03-31 | 2019-06-30 | 2019-09-30 |
| Cash | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 1 |
| Accounts Receivable | ||||||||||
| Inventory | ||||||||||
| PP&E | ||||||||||
| Assets | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 1 |
| Accounts Payable | ||||||||||
| Long-Term Debt | ||||||||||
| Liabilities | 84 | 2 | 15 | 36 | 52 | 66 | 77 | 95 | 6 | 19 |
| Stockholders' Equity | -84 | -2 | -15 | -36 | -51 | -65 | -77 | -95 | -6 | -18 |
| Income Statement ($'000) | 2017-06-30 | 2017-09-30 | 2017-12-31 | 2018-03-31 | 2018-06-30 | 2018-09-30 | 2018-12-31 | 2019-03-31 | 2019-06-30 | 2019-09-30 |
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Cost of Revenue | ||||||||||
| Gross Profit | ||||||||||
| R&D | ||||||||||
| SG&A | 8 | 8 | 8 | 9 | 9 | 8 | 8 | 7 | 8 | |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Net Income | -23 | -22 | -13 | -21 | -14 | -14 | -19 | -18 | -12 | |
| Cash Flow ($'000) | 2017-06-30 | 2017-09-30 | 2017-12-31 | 2018-03-31 | 2018-06-30 | 2018-09-30 | 2018-12-31 | 2019-03-31 | 2019-06-30 | 2019-09-30 |
| Cash Operating | -22 | -13 | -16 | -18 | -14 | -13 | -23 | -13 | ||
| Cash Investing | ||||||||||
| Cash Financing | 22 | 13 | 16 | 18 | 14 | 13 | 23 | 15 | ||